Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized Controlled Trail Using Spot Stenting to Treat Lower Extremity Post-angioplasty Dissection

NCT05562076 is registered in ClinicalTrials.gov with Zhejiang Zylox Medical Device Co., Ltd. as lead sponsor.

NCT NCT05562076
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05562076 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized Controlled Trail Using Spot Stenting to Treat Lower Extremity Post-angioplasty Dissection
Lead sponsor
Zhejiang Zylox Medical Device Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2022
Completion date
February 28, 2025
Enrollment
224 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease